HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Section

Policy

IRA, state PBM reform, Medicare, and regulatory action

Pfizer settles with 2 generic Vyndamax makers in latest twist to ATTR market: analysts
PolicyFiercePharma ↗
Eleventh-hour settlements with two of the three generic drugmakers involved could bode well for both Pfizer an…
Apr 29, 2026
PolicyAJMC ↗
Apr 28, 2026
Hikma and Amarin's generic drug case heads to Supreme Court arguments
PolicyEndpoints News ↗
When the Supreme Court hears arguments this week over a prescription-strength pill derived from fish oil, the …
Apr 28, 2026
PolicySTAT News ↗
The Supreme Court Wednesday will hear oral arguments about a simmering controversy over so-called skinny label…
Apr 28, 2026
Supreme Court grapples with multibillion-dollar wave of lawsuits over Roundup cancer claims
PolicySTAT News ↗
The Supreme Court seemed divided Monday over whether to block thousands of lawsuits alleging the maker of the …
Apr 27, 2026
Compass, Usona and Transcend score FDA national priority vouchers amid Trump administration’s psychedelic push
PolicyFierceBiotech ↗
The FDA is awarding national priority vouchers to Compass Pathways, Usona Institute and Transcend Therapeutics…
Apr 26, 2026
← Newer Page 11 Older →
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.